Skip to main content

Gemtesa Side Effects

Generic name: vibegron

Medically reviewed by Philip Thornton, DipPharm. Last updated on Jan 18, 2021.

Note: This document contains side effect information about vibegron. Some dosage forms listed on this page may not apply to the brand name Gemtesa.

Applies to vibegron: oral tablet.


Common (1% to 10%): Urinary tract infection (6.6%), urinary retention (<2%), residual urine volume increased (<2%)[Ref]


Common (1% to 10%): Hot flash (<2%)[Ref]


Common (1% to 10%): Upper respiratory tract infection (2 %), nasopharyngitis (2.8%)[Ref]

Nervous system

Common (1% to 10%): Headache (4%)[Ref]


Common (1% to 10%): Diarrhea (2.2%), constipation (<2%), nausea (2.2%), dry mouth (<2%)[Ref]


Postmarketing reports: Pruritus, rash, drug eruption, eczema[Ref]

Frequently asked questions


1. "Product Information. Gemtesa (vibegron)." Urovant Sciences, Inc (2021):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.